Drostanolone propionate
CAS: 521-12-0
Ref. 3D-FD22623
25mg | Descontinuado | ||
50mg | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado | ||
500mg | Descontinuado |
Informação sobre produto
- (2a,5a,17b)-2-Methyl-17-(1-oxopropoxy)androstan-3-one17b-Hydroxy-2a-methyl-5a-androstan-3-one propionate2a-Methyl-17b-hydroxy-5a-a ndrostan-3-one 17-propionate
- (2Alpha,5Alpha,17Beta)-2-Methyl-3-Oxoandrostan-17-Yl Propanoate
- (2α,5α,17β)-2-Methyl-17-(1-oxopropoxy)androstan-3-one
- 17b-Hydroxy-2a-methyl-5a-androstan-3-one propionate
- 17β-Hydroxy-2α-methylandrostan-3-one propionate
- 2-Methyl-3-Oxoandrostan-17-Yl Propanoate
- 2Mdtp
- 2α-Methyl-17β-hydroxy-5α-androstan-3-one 17-propionate
- 2α-Methyl-17β-propionoxy-5α-androstan-3-one
- 2α-Methyl-4,5-dihydrotestosterone propionate
- Ver mais sinónimos
- 2α-Methyl-dihydrotestosterone propionate
- 2α-Methylandrostan-17(β)-ol-3-one propionate
- 2α-Methylandrostan-17β-ol-3-one propionate
- 2α-Methyldihydrotestosterone propionate
- 32379
- 5α-Androstan-3-one, 17β-hydroxy-2α-methyl-, propionate
- Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2α,5α,17β)-
- Drolban
- Drostanolone Propionate
- Drostanolonpropionat
- Emdisterone
- Masterid
- Masteril
- Masteron
- Masterone
- Mdht
- Medrotestron propionate
- Medrotestrone propanoate
- Medrotestrone propionate
- Permastril
- Prometholone
- Propionate De Drostanolone
- Propionato De Drostanolona
Drostanolone propionate is a synthetic anabolic steroid that has been shown to inhibit the growth of renal cell cancer cells. It is used as a component of isotonic solutions for sample preparation in mouse tumor studies. Drostanolone propionate also has a role in the treatment of radiation-induced bowel disease and may be useful in the treatment of other inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. In addition, drostanolone propionate may have a potential drug target in prostate cancer tissues because it inhibits epidermal growth factor (EGF) and is converted to estradiol benzoate, which inhibits EGF-induced proliferation of prostate epithelial cells.